BC
AMGN icon

Bayforest Capital’s Amgen AMGN Stock Holding History

Bayforest Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-919
Closed -$301K – 893
2025
Q4 		$301K Buy
919
+658
+252% +$209K 0.22% 132
2025
Q3 		$73.7K Buy
261
+238
+1,035% +$69K 0.04% 557
2025
Q2 		$6.42K Sell
23
-109
-83% -$30.9K ﹤0.01% 660
2025
Q1 		$41.1K Buy
+132
New +$39K 0.02% 581

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bayforest Capital's AMGN Position: Q1 2026 in Review

Bayforest Capital sold out of Amgen (AMGN) in Q1 2026, closing a stake of 919 shares — an estimated $301K sold.

Bayforest Capital first reported a position in AMGN in Q1 2025 and held it in 4 quarters. The position peaked at $301K in Q4 2025. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bayforest Capital reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Bayforest Capital sold 919 Amgen shares in Q1 2026, an estimated $301K.
  • Bayforest Capital first reported a position in Amgen in Q1 2025 and held it in 4 quarters.
  • Bayforest Capital's Amgen position peaked at $301K in Q4 2025.
  • 3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.